Mainz Biomed (MYNZ) EBIAT (2021 - 2023)
Historic EBIAT for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to -$47.4 million.
- Mainz Biomed's EBIAT fell 47894.84% to -$47.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$55.4 million, marking a year-over-year decrease of 26785.65%. This contributed to the annual value of -$21.7 million for FY2024, which is 1766.47% up from last year.
- Per Mainz Biomed's latest filing, its EBIAT stood at -$47.4 million for Q4 2023, which was down 47894.84% from -$6.3 million recorded in Q3 2023.
- In the past 5 years, Mainz Biomed's EBIAT ranged from a high of $6.6 million in Q1 2023 and a low of -$47.4 million during Q4 2023